EXHIBIT
13.2
CERTIFICATION
PURSUANT TO
18
U.S.C. §1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of
Lorus Therapeutics Inc. (the “Company”) on Form 20-F for the period ended May
31, 2008, as filed with the Securities and Exchange Commission on the date
hereof (the “Report”), I, Elizabeth Williams, Director of Finance and Acting
Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the
best of my knowledge:
1.
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
2.
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
Date: November
26, 2008
/s/ Elizabeth
Williams
Elizabeth
Williams
Director
of Finance and Acting Chief Financial Officer